Welcome to LookChem.com Sign In|Join Free

CAS

  • or

50765-22-5

Post Buying Request

50765-22-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

50765-22-5 Usage

Uses

Methyl 3-hydroxy-5-iodobenzoate

Check Digit Verification of cas no

The CAS Registry Mumber 50765-22-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,0,7,6 and 5 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 50765-22:
(7*5)+(6*0)+(5*7)+(4*6)+(3*5)+(2*2)+(1*2)=115
115 % 10 = 5
So 50765-22-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H7IO3/c1-12-8(11)5-2-6(9)4-7(10)3-5/h2-4,10H,1H3

50765-22-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl 3-hydroxy-5-iodobenzoate

1.2 Other means of identification

Product number -
Other names METHYL 3-HYDROXY-5-IODOBENZATE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:50765-22-5 SDS

50765-22-5Relevant articles and documents

TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS

-

Paragraph 0249, (2017/04/11)

Described are compounds, which are antagonists of the P2Y14 receptor, for example, a compound of formula (I) in which ring A, R1,R2, R3, and n are as described herein. Also provided are dendron conjugates comprising the compounds, and methods of using the compounds, including a method of treating a disorder, such as inflammation, diabetes, insulin resistance, hyperglycemia, a lipid disorder, obesity, a condition associated with metabolic syndrome, and asthma, and a method of antagonizing P214 receptor activity in a cell.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 50765-22-5